Opus Genetics, Inc.(IRD) - 2025 Q4 - Annual Results
2026-02-19 21:02
Exhibit 10.1 Execution Version SECURITIES PURCHASE AGREEMENT BY AND AMONG OPUS GENETICS, INC. AND THE PURCHASERS AS SET FORTH HEREIN FEBRUARY 13, 2026 TABLE OF CONTENTS | 1. | Definitions | | 1 | | --- | --- | --- | --- | | 2. | | Purchase and Sale of Securities | 4 | | | 2.1 | Purchase and Sale | 4 | | | 2.2 | Closing | 4 | | 3. | | Representations and Warranties of the Company | 5 | | | 3.1 | Subsidiaries; Organization and Power | 5 | | | 3.2 | Capitalization | 5 | | | 3.3 | Registration Rights | 6 | | | ...
Rimini Street(RMNI) - 2025 Q4 - Annual Report
2026-02-19 21:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2025 ☐ Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period from to Commission File Number 001-37397 Rimini Street, Inc. (Exact name of registrant as specified in its charter) Delaware 36-4880301 (State or other jurisdiction of inc ...
Comfort Systems USA(FIX) - 2025 Q4 - Annual Results
2026-02-19 21:02
Exhibit 99.1 CONTACT:Julie Shaeff, Chief Accounting Officer 9753 Katy Freeway, ir@comfortsystemsusa.com; 713-830-9687 Houston, Texas 77024 Suite 700 713-830-9600 FOR IMMEDIATE RELEASE COMFORT SYSTEMS USA REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS Houston, TX — February 19, 2026 — Comfort Systems USA, Inc. (NYSE: FIX) (the "Company") today reported results for the quarter and annual period ended December 31, 2025. For the quarter ended December 31, 2025, net income was $330.8 million, or $9.37 per dil ...
Avis Budget Group(CAR) - 2025 Q4 - Annual Report
2026-02-19 21:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-10308 AVIS BUDGET GROUP, INC. (Exact name of Registrant as specified in its charter) Delaware 06-0918165 (State or other jurisdiction of incorporat ...
Weave munications(WEAV) - 2025 Q4 - Annual Results
2026-02-19 21:01
• Total revenue was $63.4 million, representing a 17.0% year-over-year increase compared to $54.2 million in the fourth quarter of 2024. • GAAP gross margin was 72.7%, compared to 72.1% in 2024. • Non-GAAP gross margin was 73.3%, compared to 72.6% in 2024. • GAAP loss from operations was $2.2 million, compared to $7.4 million in the fourth quarter of 2024. • Non-GAAP income from operations was $2.3 million, compared to $1.8 million in the fourth quarter of 2024. • GAAP net loss was $1.8 million, or $0.02 pe ...
Perdoceo Education (PRDO) - 2025 Q4 - Annual Results
2026-02-19 21:01
*See GAAP (U.S. generally accepted accounting principles) to non-GAAP reconciliations attached to this press release. PRDO ANNOUNCES 4Q25 AND FULL YEAR RESULTS …PG 1 PERDOCEO EDUCATION CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS Schaumburg, IL. (February 19, 2026) – Perdoceo Education Corporation (NASDAQ: PRDO), a provider of postsecondary education programs through its academic institutions, today reported operating and financial results for the quarter and year ended December 31, 2025. " ...
Aeglea BioTherapeutics, Inc.(AGLE) - 2025 Q4 - Annual Report
2026-02-19 21:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _________________________________________________________ FORM 10-K _________________________________________________________ x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from______ to Commission file number 001-37722 ___ ...
Spyre Therapeutics(SYRE) - 2025 Q4 - Annual Report
2026-02-19 21:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _________________________________________________________ FORM 10-K _________________________________________________________ x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from______ to Commission file number 001-37722 ___ ...
Applied Materials(AMAT) - 2026 Q1 - Quarterly Report
2026-02-19 21:01
Financial Performance - Revenue for the three months ended January 25, 2026, was $7,012 million, a decrease of 2.1% compared to $7,166 million for the same period in 2025[11] - Net income increased to $2,026 million, up 70.9% from $1,185 million year-over-year[11] - Earnings per share (EPS) for the quarter was $2.55, compared to $1.46 in the prior year, reflecting a 74.8% increase[11] - Total operating expenses rose to $1,604 million, an increase of 21.4% from $1,321 million in the same quarter last year[11] - Operating income decreased to $1,831 million, down 16% from $2,175 million in the prior year, with an operating margin of 26.1%[142] - Gross profit for the three months ended January 25, 2026, was $3,435 million, with a gross margin of 49.0%, compared to a gross margin of 48.8% in the prior year[125] Cash Flow and Liquidity - Cash provided by operating activities was $1,686 million, significantly higher than $925 million in the previous year[25] - Cash used in investing activities during the same period was $780 million, with capital expenditures totaling $646 million[169] - Cash used in financing activities was $931 million, which included $337 million for stock repurchases and $365 million in cash dividends paid[171] - The company anticipates that cash generated from operations will be sufficient to meet liquidity requirements for the next 12 months[183] Assets and Investments - Total assets increased to $37,644 million, up from $36,299 million as of October 26, 2025[18] - Total cash, cash equivalents, and investments as of January 25, 2026, amounted to $13,479 million, with cash and cash equivalents alone totaling $7,218 million[33] - The investment portfolio primarily consists of investment-grade securities, with a market value of approximately $3.3 billion as of January 25, 2026[170] Debt and Liabilities - As of January 25, 2026, the aggregate principal amount of long-term senior unsecured notes was $6.5 billion, with an estimated fair value of $6.1 billion[50] - Total long-term debt as of January 25, 2026, was $6,453 million, with various senior notes maturing between 2027 and 2050[87] - The allowance for credit losses was not material as of January 25, 2026, and October 26, 2025[65] Shareholder Returns - The company declared dividends of $0.46 per common share, totaling $365 million[22] - Dividends paid during the three months ended January 25, 2026, totaled $365 million, compared to $326 million for the same period in 2025[97] - The stock repurchase program authorized $10.0 billion in repurchases, with approximately $13.6 billion remaining available as of January 25, 2026[92] Research and Development - Research, development, and engineering expenses totaled $928 million, reflecting a significant investment in innovation and product development[125] - The company must continue investing in research and development despite economic uncertainties to maintain competitiveness[204] Market and Customer Insights - Revenue from China was $2,095 million, accounting for 30% of total revenue, while revenue from the United States decreased by 28% to $656 million[125] - The company reported that two customers accounted for approximately 19% and 16% of total revenue for the quarter, highlighting customer concentration risks[125] - The company is shifting its AGS service and spares business to a subscription model to enhance revenue predictability and optimize customer factory performance[137] Legal and Regulatory Matters - The company recorded a legal settlement charge of $253 million during the first quarter of fiscal 2026 related to a settlement agreement with the Bureau of Industry and Security (BIS)[113] - The U.S. government's export regulations have limited the company's ability to provide certain products and services to customers in China, impacting overall business operations[140] Economic and Geopolitical Risks - The company faces significant demand volatility in the semiconductor industry, influenced by factors such as technology advancements and economic conditions[202] - The company is exposed to risks from an uncertain global economy, which may lead customers to delay or reduce purchases[204] - Global trade issues and changes in trade policies have adversely affected the company's operations and competitiveness[208] - The company has faced limitations on international sales due to export license requirements, particularly affecting sales in China[209]
United Insurance(ACIC) - 2025 Q4 - Annual Results
2026-02-19 21:01
Exhibit 99.1 FOR IMMEDIATE RELEASE AMERICAN COASTAL INSURANCE CORPORATION REPORTS FINANCIAL RESULTS FOR ITS FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2025 Company to Host Quarterly Conference Call at 5:00 P.M. ET on February 19, 2026 The information in this press release should be read in conjunction with an earnings presentation that is available on the Company's website at investors.amcoastal.com/events-and-presentations. St. Petersburg, FL - February 19, 2026: American Coastal Insurance Corporation (Nas ...